Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

(1982): Bailin PL+, Clin Rheum Dis 8, 493 (passim)
Pruritus (10%)
(1990): Fremont-Smith P+, Ann Rheum Dis 49, 271
(1989): Caspi D+, Ann Rheum Dis 48, 730
(1984): Grindulis KA+, Ann Rheum Dis 43, 398
(1982): Smith PJ+, Br Med J (Clin Res Ed) 285, 595
Seborrheic dermatitis
(1982): Bailin PL+, Clin Rheum Dis 8, 493 (passim)
(1981): Kanwar AJ+, Arch Dermatol 117, 65 (passim)
Squamous cell carcinoma
(1990): Miller RA+, JAmAcadDermatol23, 360 (from
radioactive gold)
toxic dermatitis (sic)
Toxic epidermal necrolysis
(1998): Pandya AG+, Arch Dermatol 134, 1104 (passim)
(1982): Braun-Falco O+, MMM Munch Med Wochenschr
(German) 124, 757 (with benoxaprofen)
(1982): Feldman C+, Rheumatol Rehabil 21, 222 (with
benoxaprofen)
Toxicoderma
(1985): Kalamkarian AA+, Vestn Dermatol Venerol (8), 4
Urticaria (1–10%)
(1998): Pandya AG+, Arch Dermatol 134, 1104 (passim)
(1994): Lizeaux-Parneix V+, Ann Dermatol Venereol (French)
121, 793
(1982): Bailin PL+, Clin Rheum Dis 8, 493 (passim)
Vasculitis
(1984): Hauteville D+, Rev Rhum Mal Osteoartic (French) 51, 56
(1982): Bailin PL+, Clin Rheum Dis 8, 493 (passim)
Vitiligo
Xerosis
(1984): Grindulis KA+, Ann Rheum Dis 43, 398
Mucosal
Aphthous stomatitis
(1989): Caspi D+, Ann Rheum Dis 48, 730
(1988): Tishler M+, Ann Rheum Dis 47(3), 215
Burning mouth syndrome
(1994): Laeijendecker R+, JAmAcadDermatol30, 205
Cheilitis
(1982): Bailin PL+, Clin Rheum Dis 8, 493 (passim)
Gingivitis (>10%)
Gingivostomatitis
(1982): Izumi AK, Arch Dermatol Res 272, 387 (allergic contact)
Glossitis (>10%)
Mucocutaneous reactions
(1996): Cheatum DE, J Rheumatol 23, 944
(1995): Klinkhoff AV+, J Rheumatol 22, 1657
Oral lichen planus
(1994): Laeijendecker R+, JAmAcadDermatol30, 205
(1994): Lizeaux-Parneix V+, Ann Dermatol Venereol (French)
121, 793
(1993): Brown RS+, Cutis 51, 183
Oral lichenoid eruption
GOLD AND GOLD COMPOUNDS 257
(1990): Vallejo-Irastorza G+, Av Odontoestomatol (Spanish)
6, 131
Oral mucosal eruption
Oral pigmentation
(1990): Torrelo A+, Actas Dermo-Sif (Spanish) 81, 743
(1984): Sutak J+, Prakt Zubn Lek (Czech) 32, 166
Oral ulceration
(2000): Madinier I+, Ann Med Interne (Paris) (French) 151, 248
(1999): Räsänen L+, Br J Dermatol 141, 683
(1984): Glenert U, Oral Surg 58, 52
(1982): Bailin PL+, Clin Rheum Dis 8, 493 (passim)
Stomatitis (>10%)
(2001): Werth V, Dermatology Times 18
(1997): Tosti A+, Semin Cutan Med Surg 16, 314
(1996): Bonnetblanc JM, Presse Med (French) 25, 1555
(1994): Laeijendecker R+, JAmAcadDermatol30, 205
(1992): Svensson A+, Ann Rheum Dis 51, 326
(1989): Caspi D+, Ann Rheum Dis 48, 730
(1987): Tumiati B+, J Rheumatol 14, 177
(1984): Glenert U, Oral Surg 58, 52
(1983): Sigler JW, Am J Med 75, 59
(1982): Bailin PL+, Clin Rheum Dis 8, 493 (passim)
Vaginitis
Hair
Hair – alopecia (1–10%)
(1998): Pandya AG+, Arch Dermatol 134, 1104 (passim)
(1984): Grindulis KA+, Ann Rheum Dis 43, 398
(1982): Bailin PL+, Clin Rheum Dis 8, 493 (passim)
Hair – pigmentation
Nails
Nails – dystrophy
(2005): Yokozeki H+, Br J Dermatol 152(5), 1087
Nails – exfoliation
Nails – lichen planus
(1990): Torrelo A+, Actas Dermo-Sif (Spanish) 81, 743
Nails – loss
(2000): ter Borg EJ+, Arthritis Rheum 43, 1420
Nails – onycholysis
Nails – pigmentation
(2001): Roest MA+, Br J Dermatol 145, 186
(1984): Fam AG+, Arthritis Rheum 27, 119 (gold nails)
Other
Anaphylactoid reactions/Anaphylaxis
Death
(1991): Van Linthoudt D+, Schweiz Med Wochenschr
121(30), 1099
Hypersensitivity
Injection-site pain
(1984): Grindulis KA+, Ann Rheum Dis 43, 398
Nephrotoxicity
(2004): Ohno I+, Nippon Rinsho 62(10), 1919
Pseudolymphoma
(2002): Kim KJ+, Br J Dermatol 146, 882 (gold acupuncture)
(1996): Kalimo K+, JCutanPathol23, 328
(1993): Kerl H+, Dermatology in General Medicine McGraw-Hill
New York
Note: Adverse reactions can occur months after therapy has been
discontinued